In fact, platelets of T2D patients have decreased sensitivity to insulin, which may lead to increased platelet reactivity and a higher risk of atherothrombotic events among insulin-treated subjects (Ferreira et al., 2006). This evidence concerns the gene INS and type 2 diabetes mellitus.